In May 2019 Ethical Consumer viewed the Teva page on the Open Secrets website which stated that the company and its employees had given $111,973 to political parties in 2018, with 62% going to Democrats. It had also spent $2,610,000 on lobbying.

Reference:

Open Secrets generic ref 2019 (2 January 2019)

In May 2019 Ethical Consumer viewed its list of members of lobby groups that it considered to push for free trade solutions at the expense of human rights, democracy or the environment, updated in February 2019. Teva was a member of one such group: American Legislative Exchange Council. It was thus marked down in the political activities category.

Reference:

Ethical Consumer Lobby Group member list (7 February 2019)

An article in The Wall Street Journal on the 11th of February 2015 reported that Teva Pharmaceutical Industries Ltd had said in a securities filing that an internal investigation had turned up business practices that were “likely” violations of the Foreign Corrupt Practices Act.
The drugmaker had previously said it was looking into “issues” in a number of countries around the world that “could rise to the level of FCPA violations and/or violations of local law,” according to a 2014 securities filing.
The company said its internal probe began after it received subpoenas and other requests for information related to foreign bribery from the Securities and Exchange Commission and Justice Department starting in 2012. The company’s investigation had since turned up business practices and transactions in Russia, Eastern Europe and Latin America that are “likely” violations of the FCPA and local laws, it said in the recent filing.
Teva had previously said that it may have to pay “material fines” in connection with the FCPA probe. Teva had also said that “affiliates in certain countries under investigation” gave local authorities “inaccurate or altered information” on marketing and promotion practices. A company spokeswoman declined to comment.

Reference:

Teva Finds ‘Likely’ FCPA Violations (11 February 2015)

In May 2019 Ethical Consumer viewed Teva's form DEF14a. It contained details of several senior staff which were paid more than £1 million in 2018, the amount that Ethical Consumer considered excessive. The highest paid receieved $10,799,996.

Reference:

Teva form DEF14a (13 May 2019)

In May 2019 Ethical Consumer viewed the Teva family tree on the corporate website hoovers.com. The company had several high risk subsidiaries in jurisdictions that Ethical Consumer considered to be tax havens at the time of writing, namely holding companies in the Netherlands. The company's annual report was checked but it contained no country-by-country reporting. As a result Teva received Ethical Consumer's worst rating for likely use of tax avoidance strategies.

Reference:

Generic Hoovers ref 2019 (2 January 2019)